Christopher M Lindblom - Net Worth and Insider Trading

Christopher M Lindblom Net Worth

The estimated net worth of Christopher M Lindblom is at least $0 dollars as of 2024-06-09. Christopher M Lindblom is the See Remarks of Infinity Pharmaceuticals Inc and owns about 2,158 shares of Infinity Pharmaceuticals Inc (INFIQ) stock worth over $0. Details can be seen in Christopher M Lindblom's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Christopher M Lindblom has not made any transactions after 2012-11-26 and currently still holds the listed stock(s).

Transaction Summary of Christopher M Lindblom

To

Christopher M Lindblom Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Christopher M Lindblom owns 4 companies in total, including Infinity Pharmaceuticals Inc (INFIQ) , DNIB Unwind Inc (BINDQ) , and Millendo Therapeutics Inc (MLND) among others .

Click here to see the complete history of Christopher M Lindblom’s form 4 insider trades.

Insider Ownership Summary of Christopher M Lindblom

Ticker Comapny Transaction Date Type of Owner
INFIQ Infinity Pharmaceuticals Inc 2016-05-02 Principal Accounting Officer
BINDQ DNIB Unwind Inc 2015-03-07 SVP & FINANCE & ADMINISTRATION
MLND Millendo Therapeutics Inc 2013-06-07 Vice President of Finance
LIMIT LIMIT 2013-06-07 Vice President of Finance

Christopher M Lindblom Latest Holdings Summary

Christopher M Lindblom currently owns a total of 1 stock. Christopher M Lindblom owns 2,158 shares of Infinity Pharmaceuticals Inc (INFIQ) as of November 26, 2012, with a value of $0.

Latest Holdings of Christopher M Lindblom

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
INFIQ Infinity Pharmaceuticals Inc 2012-11-26 2,158 0.00 0

Holding Weightings of Christopher M Lindblom


Christopher M Lindblom Form 4 Trading Tracker

According to the SEC Form 4 filings, Christopher M Lindblom has made a total of 0 transactions in Infinity Pharmaceuticals Inc (INFIQ) over the past 5 years. The most-recent trade in Infinity Pharmaceuticals Inc is the sale of 13,885 shares on November 26, 2012, which brought Christopher M Lindblom around $357,261.

Insider Trading History of Christopher M Lindblom

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Christopher M Lindblom Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Christopher M Lindblom Ownership Network

Ownership Network List of Christopher M Lindblom

No Data

Ownership Network Relation of Christopher M Lindblom

Insider Network Chart

Christopher M Lindblom Owned Company Details

What does Infinity Pharmaceuticals Inc do?

Who are the key executives at Infinity Pharmaceuticals Inc?

Christopher M Lindblom is the Principal Accounting Officer of Infinity Pharmaceuticals Inc. Other key executives at Infinity Pharmaceuticals Inc include director & President & CEO Adelene Q Perkins , Chief Scientific Officer Stephane Peluso , and Chief Medical Officer Robert Jr. Ilaria .

Infinity Pharmaceuticals Inc (INFIQ) Insider Trades Summary

Over the past 18 months, Christopher M Lindblom made no insider transaction in Infinity Pharmaceuticals Inc (INFIQ). Other recent insider transactions involving Infinity Pharmaceuticals Inc (INFIQ) include a net sale of 410,196 shares made by Adelene Q Perkins ,

In summary, during the past 3 months, insiders sold 0 shares of Infinity Pharmaceuticals Inc (INFIQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 410,196 shares of Infinity Pharmaceuticals Inc (INFIQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 410,196 shares.

Infinity Pharmaceuticals Inc (INFIQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Infinity Pharmaceuticals Inc Insider Transactions

No Available Data

Christopher M Lindblom Mailing Address

Above is the net worth, insider trading, and ownership report for Christopher M Lindblom. You might contact Christopher M Lindblom via mailing address: C/o Infinity Pharmaceuticals, Inc., 780 Memorial Drive, Cambridge Ma 02139.

Discussions on Christopher M Lindblom

No discussions yet.